In his new role leading the Chan Zuckerberg Biohub New York, Andrea Califano will bring together scientists from several universities to engineer the immune system to detect and treat disease.
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
With high precision, a new algorithm predicts which patients treated for traumatic injuries in the emergency department will later develop post-traumatic stress disorder.
Kidney complications were more common in New York City COVID-19 patients than in COVID-19 patients from other regions, a new single-center study from Columbia researchers has found.
Columbia University's new "COVID-19 Trial Finder" is a simplified method for patients, clinicians, and healthy volunteers to find appropriate COVID clinical trials near their home.
The fluctuations of gut microbial communities follow ecological principles developed for animals and financial markets, which may help to predict disease biomarkers and effects of unhealthy diets.
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.